Valvular Aortic Valve archivos

Structural heart disease

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic...

Dr. Andrés Rodríguez - 20 November, 2024

Coronary disease

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary...

Dr. Omar Tupayachi - 13 November, 2024

Mitral valve

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality. Edge-to-edge repair has...

Dr. Carlos Fava - 11 November, 2024

Structural Heart Disease

TCT 2024 – TAVR UNLOAD: Moderate Aortic Stenosis with Ventricular Function Deterioration

The prevalence of aortic stenosis (AS) is on the rise in developed countries, and the link between...

Dr. Carlos Fava - 7 November, 2024

Coronary disease

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation...

Dr. Carlos Fava - 5 November, 2024

Antithrombotic Anticoagulants

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series....

Dr. Carlos Fava - 24 October, 2024

Structural heart disease

ENVISAGE-TAVI AF Trial: What Anticoagulant Should We Use?

Between 15% and 30% of patients undergoing TAVR present atrial fibrillation. Many of them have suffered ischemic...

Dr. Carlos Fava - 23 September, 2024

Mitral valve

Evolution at 1 Year for the PARTNER 3 Mitral Valve-in-Valve Study

At present, the structural failure of mitral bioprostheses due to their deterioration poses a significant challenge. While...

Dr. Carlos Fava - 20 September, 2024

Valvular Aortic Valve

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

TCT 2024 – TAVR UNLOAD: Moderate Aortic Stenosis with Ventricular Function Deterioration

Evolution of Small Balloon-Expandable Valves

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

ENVISAGE-TAVI AF Trial: What Anticoagulant Should We Use?

Evolution at 1 Year for the PARTNER 3 Mitral Valve-in-Valve Study

Últimas Noticias

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Check out the best images of the Arequipa 2024 Sessions

Accesos